In the present study, we measured the plasma FAPα level in cancer patients and investigated the associations between circulating FAPα and patients’ clinical outcomes to evaluate the clinical value of plasma FAPα as diagnostic parameter in ESCC patients. This evidence concerns the gene FAP and cancer.